Significant Ownership of Nicholas J. Singer

Location
Miami, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Nicholas J. Singer.

Notify me when Nicholas J. Singer files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Nicholas J. Singer

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ERNA Eterna Therapeutics Inc. Common stock, par value $0.005 per share 4.9% $538,650 2,565,001 Nicholas Jason Singer 31 Dec 2024

Schedules 13D/G Reported by Nicholas J. Singer:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.